Sarasota, Fla. (PRWEB) November 19, 2013
Rapid Pathogen Screening, Inc. (RPS®) – an emerging developer of point-of-care diagnostic tests – is a national partner for The United States’ Centers for Disease Control and Prevention’s (CDC) Get Smart About Antibiotics Week from November 18-24.
Get Smart About Antibiotics Week is a national campaign designed to highlight the coordinated efforts of CDC, state and local health departments, and non-profit and for-profit partners in an effort to provide education about the importance of using antibiotics wisely in both community and healthcare settings.
“Misuse of antibiotics is not only a national healthcare epidemic but also a mounting global problem that is rendering existing treatments inadequate and contributing to the growing number of antibiotic-resistant bacteria,” said Robert Sambursky, MD, chief executive officer, president and chairman of RPS. “RPS is proud to partner again this year with the CDC to help increase awareness of the critical issue of antibiotics overuse and over-prescription by underscoring the root of the problem clinicians face – the differential diagnosis of viral and bacterial infections.”
During Get Smart About Antibiotics Week, the CDC will promote appropriate antibiotic use in inpatient and outpatient settings through a “Ground Rounds” national webcast on Tuesday, November 19 at 1 pm EST titled Combating Resistance: Getting Smart About Antibiotics and during a Twitter Chat on Friday, November 22 at 1 pm EST. Members of the media are encouraged to join the conversation by using the hashtag #SaveAbx and following @CDCgov.
Today, infections with antibiotic-resistant bacteria have become increasingly common in both healthcare and community settings. As such, patients, healthcare providers, hospital administrators, and policy makers must work together to employ safe and effective strategies for improving antibiotic use. CDC's Get Smart: Know When Antibiotics Work and Get Smart for Healthcare programs are specifically designed to educate consumers and healthcare providers about appropriate use of antibiotics.
Founded in 2004, Rapid Pathogen Screening, Inc. (RPS®) is an emerging developer, manufacturer, and marketer of rapid point-of-care (POC) diagnostic tests. The company’s innovative and patented technology platform facilitates the development of a spectrum of cost-effective tests to support the rapid diagnosis of patients with infectious diseases and inflammatory conditions. As a result of U.S. government contracts, this platform is also being developed to help detect the body’s immune response to viral and bacterial infections as well as chemical nerve agent blood toxins. RPS tests have high sensitivity and specificity, and can be easily performed by a clinician or their staff without extensive training or additional equipment. For more information on RPS or its products, visit RPSdetectors.com.
For additional information, contact:
Laura Lovejoy, 941.928.9025, laura(at)saranova(dot)net